Claire A Przybyla

Title: Innovations of Claire A Przybyla

Introduction

Claire A Przybyla is a prominent inventor based in Des Plaines, IL (US). She has made significant contributions to the field of chemistry, particularly in the development of retroviral protease inhibitors. With a total of 14 patents to her name, her work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Among her latest patents is a method of preparing intermediates useful in the synthesis of retroviral protease inhibitors. This synthesis involves the formation of a diastereoselective epoxide from a chiral alpha amino aldehyde, which is crucial for the large-scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors. Another notable patent describes a method of preparing retroviral protease inhibitor intermediates. This method allows for the cost-effective production of chiral hydroxyethylamine, hydroxyethylurea, or hydroxyethylsulfonamide isostere containing retroviral protease and renin inhibitors. The multi-step syntheses utilize key chiral amine intermediates that are enantiomerically, diastereomerically, and chemically pure, making it suitable for large-scale production.

Career Highlights

Claire has worked with notable companies such as G.D. Searle & Company and G.D. Searle LLC. Her experience in these organizations has contributed to her expertise in the pharmaceutical industry and her ability to innovate in the field of drug development.

Collaborations

Throughout her career, Claire has collaborated with esteemed colleagues, including John S Ng and Richard A Mueller. These partnerships have further enhanced her research and development efforts.

Conclusion

Claire A Przybyla's contributions to the field of chemistry and her innovative patents have made her a significant figure in the development of retroviral protease inhibitors. Her work continues to influence the pharmaceutical industry and improve treatment options for patients.